Skip to main navigation Skip to search Skip to main content

MRC IAA Development of a bivalent nanobody to GPVI and human albumin as a novel anti-thrombotic therapy

Project Details

Short titleMRC IAA Development of a bivalent nanobody to GPVI and human albumin as a novel anti-thrombotic therapy
StatusFinished
Effective start/end date1/02/2431/12/25

Funding

  • Medical Research Council